| 中文名称 | Harpagoside 哈巴俄苷 |
|---|---|
| 中文别名 | 哈巴俄苷;哈巴俄甙;哈巴甙;钩果草甙;玄生甙;爪钩草酯苷;钩果草提取物;哈巴俄苷 EP标准品;哈巴俄苷 标准品;哈巴俄苷(标准品);哈巴俄苷(钩果草甙、玄生甙、爪钩草酯苷);哈巴俄苷,Harpagoside,植物提取物,标准品,对照品;哈巴俄苷Harpagoside;玄参提取物;哈巴脂苷;哈帕酯甙;哈巴俄苷,钩果草苷;哈巴苷;哈巴俄苷/哈巴苷;哈巴俄苷(对照品) |
| 英文别名 | Harpagosid;8'-CINNAMOYLHARPAGIDE;8-O-E CINNAMOYL HARPAGIDE;HARPAGOSIDE;[1S-[1alpha,4aalpha,5alpha,7alpha(E),7aalpha]]-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[(allyl-1-oxo-3-phenyl)oxy]cyclopenta[c]pyran-1-yl-beta-D-glucopyranoside;Harpogoside;HARPAGOSIDE hplc;[(1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate;HARPAGOSIDE WITH HPLC;7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl;β-D-Glucopyranoside, (1S,4aS,5R,7S,7aS)-1,4a,5,6;[(1S)-1,4a,5,6,7,7aα-Hexahydro-4aα,5α-dihydroxy-7-methyl-7α-[[(E)-1-oxo-3-phenyl-2-propenyl]oxy]cyclopenta[c]pyran-1α-yl]β-D-glucopyranoside;b-D-Glucopyranoside,(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl;HARPAGOSIDE(P);HARPAGOSIDE(RG);Einecs 242-881-6;[ "" ];side;Harpa;Harpagoside ,98%;8KGS1DC5ZU;SMR001233395;Harpaside;E-harpagoside;Prestwick3_000988;BSPBio_001055;MLS002473324;MLS002154086;BPBio1_001161;MEGxp0_000469;Harpagoside, analytical standard;KVRQGMOSZKPBNS-FMHLWDFHSA-N;HMS2231N12;HMS2098E17;[(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[;A880338;C09783;(1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate;CS-0008931;BRD-K07996107-001-03-3;.BETA.-D-GLUCOPYRANOSIDE, (1S,4AS,5R,7S,7AS)-1,4A,5,6,7,7A-HEXAHYDRO-4A,5-DIHYDROXY-7-METHYL-7-(((2E)-1-OXO-3-PHENYL-2-PROPENYL)OXY)CYCLOPENTA(C)PYRAN-1-YL;NCGC00179325-02;Q-100231;SCHEMBL893387;AB00513986;s9171;CCG-269650;NS00101087;(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate;(1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-D-glucopyranoside;HARPAGOSIDE [WHO-DD];Harpagoside, European Pharmacopoeia (EP) Reference Standard;H10494;HY-N0396;19210-12-9;LMPR0102070010;MFCD00017415;NCGC00179325-01;NCGC00179325-04;CHEBI:5625;EN300-7357122;Q25099323;ACon1_000134;HARPAGOSIDE [INCI];AS-56071;DTXSID101032528;beta-D-GLUCOPYRANOSIDE, (1S,4AS,5R,7S,7AS)-1,4A,5,6,7,7A-HEXAHYDRO-4A,5-DIHYDROXY-7-METHYL-7-(((2E)-1-OXO-3-PHENYL-2-PROPENYL)OXY)CYCLOPENTA(C)PYRAN-1-YL;AKOS015896715;(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyran-7-yl (2E)-3-phenylprop-2-enoate;CHEMBL516702;Harpagoside, primary pharmaceutical reference standard;BRD-K079... |
| CAS号 | 19210-12-9 |
| 分子式 | C24H30O11 |
| 分子量 | 494.49 |
| 密度 | 1.52 |
| 沸点 | 720.7℃/760mmHg |
Copyright ©2024 北京睿宸生物科技有限公司 版权所有 备案号：京ICP备2023008432号-1
